These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

228 related articles for article (PubMed ID: 18044180)

  • 1. Update on bazedoxifene: a novel selective estrogen receptor modulator.
    Biskobing DM
    Clin Interv Aging; 2007; 2(3):299-303. PubMed ID: 18044180
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy and safety of bazedoxifene, a novel selective estrogen receptor modulator for the prevention and treatment of postmenopausal osteoporosis.
    Palacios S
    Curr Med Res Opin; 2010 Jul; 26(7):1553-63. PubMed ID: 20429824
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bazedoxifene: bazedoxifene acetate, TSE 424, TSE-424, WAY 140424.
    Drugs R D; 2008; 9(3):191-6. PubMed ID: 18457472
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bone: in search of the perfect SERM--a 5-year study of bazedoxifene.
    Schneider DL
    Nat Rev Endocrinol; 2011 Sep; 7(11):634-5. PubMed ID: 21931371
    [No Abstract]   [Full Text] [Related]  

  • 5. Bazedoxifene: a third-generation selective estrogen receptor modulator for treatment of postmenopausal osteoporosis.
    Stump AL; Kelley KW; Wensel TM
    Ann Pharmacother; 2007 May; 41(5):833-9. PubMed ID: 17426077
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bazedoxifene (Wyeth).
    Gruber C; Gruber D
    Curr Opin Investig Drugs; 2004 Oct; 5(10):1086-93. PubMed ID: 15535430
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bazedoxifene acetate: a novel selective estrogen receptor modulator for the prevention and treatment of postmenopausal osteoporosis.
    Chines AA; Komm BS
    Drugs Today (Barc); 2009 Jul; 45(7):507-20. PubMed ID: 19834628
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Therapeutic agents for disorders of bone and calcium metabolism: Bazedoxifene].
    Chaki O
    Clin Calcium; 2007 Jan; 17(1):30-5. PubMed ID: 17211091
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An update on selective estrogen receptor modulators for the prevention and treatment of osteoporosis.
    Komm BS; Chines AA
    Maturitas; 2012 Mar; 71(3):221-6. PubMed ID: 22196312
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bazedoxifene and bazedoxifene combined with conjugated estrogens for the management of postmenopausal osteoporosis.
    Lewiecki EM
    Expert Opin Investig Drugs; 2007 Oct; 16(10):1663-72. PubMed ID: 17922629
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bazedoxifene: a new selective estrogen receptor modulator for postmenopausal osteoporosis.
    Genant HK
    Menopause Int; 2011 Jun; 17(2):44-9. PubMed ID: 21693498
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bazedoxifene: a novel selective estrogen receptor modulator for postmenopausal osteoporosis.
    de Villiers TJ
    Climacteric; 2010 Jun; 13(3):210-8. PubMed ID: 20184423
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bazedoxifene: a new selective estrogen receptor modulator for the treatment of postmenopausal osteoporosis.
    Kung AW; Chu EY; Xu L
    Expert Opin Pharmacother; 2009 Jun; 10(8):1377-85. PubMed ID: 19445558
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Current and emerging pharmacologic therapies for the management of postmenopausal osteoporosis.
    Lewiecki EM
    J Womens Health (Larchmt); 2009 Oct; 18(10):1615-26. PubMed ID: 19857095
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tissue-selective estrogen complexes for postmenopausal women.
    Mirkin S; Komm BS
    Maturitas; 2013 Nov; 76(3):213-20. PubMed ID: 23849704
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Assessment of the safety of long-term bazedoxifene treatment on the reproductive tract in postmenopausal women with osteoporosis: results of a 7-year, randomized, placebo-controlled, phase 3 study.
    Palacios S; de Villiers TJ; Nardone Fde C; Levine AB; Williams R; Hines T; Mirkin S; Chines AA;
    Maturitas; 2013 Sep; 76(1):81-7. PubMed ID: 23871271
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bazedoxifene acetate for the management of postmenopausal osteoporosis.
    Palacios S
    Drugs Today (Barc); 2011 Mar; 47(3):187-95. PubMed ID: 21494696
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bazedoxifene: a review of its use in the treatment of postmenopausal osteoporosis.
    Duggan ST; McKeage K
    Drugs; 2011 Nov; 71(16):2193-212. PubMed ID: 22035517
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Use of SERMs for treatment in postmenopausal women.
    Pinkerton JV; Thomas S
    J Steroid Biochem Mol Biol; 2014 Jul; 142():142-54. PubMed ID: 24373794
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The discovery and development of selective estrogen receptor modulators (SERMs) for clinical practice.
    Maximov PY; Lee TM; Jordan VC
    Curr Clin Pharmacol; 2013 May; 8(2):135-55. PubMed ID: 23062036
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.